President, Representative Director Terukazu Kato PLAY LIST from the beginning Business Results for Fiscal 2018 Consolidated Performance for Fiscal 2018 Second Medium-Term Management Plan (FY 2016 - FY 2018) Summary Historical 10-Year ROE Trends (FY 2009 - FY 2018) Annual Average Growth Rate for Three Drug-fostering Formulations (Daikenchuto, Yokukansan & Rikkunshito) Issues with Quantitative Goals Progress with Long-Term Business Vision Long-Term Business Vision for 2021 The Kampo Company -Diverse Delivery Track Record to a Number of Facilities- The Kampo Company -Rise in Doctors Prescribing 10 or More Prescription Kampo Products- The Kampo Company -Sales Volume Trends for 129 Prescription Kampo Products- The Kampo Company -Kampo Medical Training at Universities and Medical Schools- The Kampo Company -Medical Education Model Core Curriculum- The “People” Company -Establish the Tsumura Academy- The “Global Niche” Company -Development of TU-100 (Daikenchuto)- [1] The “Global Niche” Company -Development of TU-100 (Daikenchuto)- [2] The “Global Niche” Company -Business in China- Cash Flows (FY 2016 - FY 2018) Trends for Inventory Assets & Sales of 129 Prescription Kampo Products CAPEX Reference Materials Consolidated Performance in Fiscal 2018 Key Points in Performance Factors in Increase / Decrease of Operating Profit Financial Condition / Cash Flow Position FY 2018 Sales Trends for Top 10 Ranking Prescription Kampo Products Inquiries related to these materials Third Medium-Term Management Plan (Fiscal 2019 - Fiscal 2021) Philosophy-Based Management Long-Term Business Vision for 2021 Roadmap to Realizing Our Long-Term Vision Business Environment: Demographics Business Environment: Demand for Kampo Preparations Based on NDB Open Data Business Environment: The Number of Patients with Dementia Business Environment: Change in Female Employment Rate Business Environment: The Number of Cancer Sufferers Business Environment: The Chinese Market [1] Business Environment: The Chinese Market [2] Business Environment: The Chinese Market [3] Numerical Targets (FY 2021) Business Strategy Strategic Challenges Sales Measures Building Evidence TU-100 (Daikenchuto) Development The Chinese Business [1] The Chinese Business [2] Efficiency Measures to Improve Productivity Optimizing the Overall Group Supply Chain Effective Resource Distribution Training Personnel Who Can Implement Philosophy-Based Management Efforts Towards SDGs Shareholder Return Policy FY 2019 Earnings Forecast Inquiries related to these materials Back Next